BRAFフュージョンの腫瘍無関係なゲノムおよび臨床分析からの補足表4：アクショナブルターゲットの特定

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Supplemental Table 4 from Tumor-Agnostic Genomic and Clinical Analysis of <i>BRAF</i> Fusions Identifies Actionable Targets2024
2. 2Supplemental Table 1 from Tumor-Agnostic Genomic and Clinical Analysis of <i>BRAF</i> Fusions Identifies Actionable Targets2024
3. 3Supplemental Table 1 from Tumor-Agnostic Genomic and Clinical Analysis of <i>BRAF</i> Fusions Identifies Actionable Targets2024
4. 4Supplemental Table 3 from Tumor-Agnostic Genomic and Clinical Analysis of <i>BRAF</i> Fusions Identifies Actionable Targets2024
5. 5Supplemental Table 3 from Tumor-Agnostic Genomic and Clinical Analysis of <i>BRAF</i> Fusions Identifies Actionable Targets2024